Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.
| Registrars: |
| CEO: | Timothy J Mitchell |
| Non-Executive Director: | Clive Birch, Michael Owen |
| Executive Director: | John C Reader |
| Non-Executive Chairman: | Stephen Parker |
| Address: | Unit 2A, Langford Arch,London Road, Pampisford, Cambridge, Cambridgeshire, United Kingdom |
| Phone: | +44 (0) 1223 497700 |
| Fax: | +44 (0) 1223 497701 |
| Website: | http://www.sareum.co.uk |
| Email: |
| ISIN: | GB00BMC3RJ87 |
| Sector: | Pharma and Biotech, Pharma and Biotech |
| Main Indices: | FTSE AIM All-Share |